156 related articles for article (PubMed ID: 3179437)
1. Iron mobilization from hepatocyte monolayer cultures by chelators: the importance of membrane permeability and the iron-binding constant.
Porter JB; Gyparaki M; Burke LC; Huehns ER; Sarpong P; Saez V; Hider RC
Blood; 1988 Nov; 72(5):1497-503. PubMed ID: 3179437
[TBL] [Abstract][Full Text] [Related]
2. Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture.
Hershko C; Link G; Pinson A; Peter HH; Dobbin P; Hider RC
Blood; 1991 May; 77(9):2049-53. PubMed ID: 2018841
[TBL] [Abstract][Full Text] [Related]
3. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
Zevin S; Link G; Grady RW; Hider RC; Peter HH; Hershko C
Blood; 1992 Jan; 79(1):248-53. PubMed ID: 1728313
[TBL] [Abstract][Full Text] [Related]
4. Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study.
Gaboriau F; Chantrel-Groussard K; Rakba N; Loyer P; Pasdeloup N; Hider RC; Brissot P; Lescoat G
Biochem Pharmacol; 2004 Apr; 67(8):1479-87. PubMed ID: 15041465
[TBL] [Abstract][Full Text] [Related]
5. Selection of hydroxypyridin-4-ones for the treatment of iron overload using in vitro and in vivo models.
Huehns ER; Porter JB; Hider RC
Hemoglobin; 1988; 12(5-6):593-600. PubMed ID: 3209401
[TBL] [Abstract][Full Text] [Related]
6. Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization.
Vlachodimitropoulou Koumoutsea E; Garbowski M; Porter J
Br J Haematol; 2015 Sep; 170(6):874-83. PubMed ID: 26033030
[TBL] [Abstract][Full Text] [Related]
7. The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelators.
Hershko C; Theanacho EN; Spira DT; Peter HH; Dobbin P; Hider RC
Blood; 1991 Feb; 77(3):637-43. PubMed ID: 1991172
[TBL] [Abstract][Full Text] [Related]
8. Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells.
Glickstein H; Breuer W; Loyevsky M; Konijn AM; Shanzer A; Cabantchik ZI
Blood; 1996 Jun; 87(11):4871-8. PubMed ID: 8639861
[TBL] [Abstract][Full Text] [Related]
9. Mobilization of intracellular iron by analogs of pyridoxal isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes.
Buss JL; Arduini E; Ponka P
Biochem Pharmacol; 2002 Dec; 64(12):1689-701. PubMed ID: 12445858
[TBL] [Abstract][Full Text] [Related]
10. Multidentate pyridinones inhibit the metabolism of nontransferrin-bound iron by hepatocytes and hepatoma cells.
Chua AC; Ingram HA; Raymond KN; Baker E
Eur J Biochem; 2003 Apr; 270(8):1689-98. PubMed ID: 12694182
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94.
Chenoufi N; Hubert N; Loréal O; Morel I; Pasdeloup N; Cillard J; Brissot P; Lescoat G
J Hepatol; 1995 Aug; 23(2):166-73. PubMed ID: 7499788
[TBL] [Abstract][Full Text] [Related]
12. Cytoprotection and iron mobilization in rat hepatocyte cultures by a new synthetic dihydroxamate chelator.
Rakba N; Nguyen-Van-Duong MK; Nicolas L; Guillot V; Morel I; Pasdeloup N; Brissot P; Lescoat G
Toxicol Lett; 1999 Oct; 110(1-2):19-27. PubMed ID: 10593591
[TBL] [Abstract][Full Text] [Related]
13. Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes.
Ma Y; de Groot H; Liu Z; Hider RC; Petrat F
Biochem J; 2006 Apr; 395(1):49-55. PubMed ID: 16336208
[TBL] [Abstract][Full Text] [Related]
14. Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator.
Vlachodimitropoulou E; Chen YL; Garbowski M; Koonyosying P; Psaila B; Sola-Visner M; Cooper N; Hider R; Porter J
Blood; 2017 Oct; 130(17):1923-1933. PubMed ID: 28864815
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values.
Liu ZD; Piyamongkol S; Liu DY; Khodr HH; Lu SL; Hider RC
Bioorg Med Chem; 2001 Mar; 9(3):563-73. PubMed ID: 11310590
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of iron mobilization from haemosiderin, ferritin and iron(III) precipitates by chelators.
Kontoghiorghes GJ; Chambers S; Hoffbrand AV
Biochem J; 1987 Jan; 241(1):87-92. PubMed ID: 3566714
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
Rai BL; Dekhordi LS; Khodr H; Jin Y; Liu Z; Hider RC
J Med Chem; 1998 Aug; 41(18):3347-59. PubMed ID: 9719587
[TBL] [Abstract][Full Text] [Related]
18. Structure-function investigation of the interaction of 1- and 2-substituted 3-hydroxypyridin-4-ones with 5-lipoxygenase and ribonucleotide reductase.
Kayyali R; Porter JB; Liu ZD; Davies NA; Nugent JH; Cooper CE; Hider RC
J Biol Chem; 2001 Dec; 276(52):48814-22. PubMed ID: 11602611
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine.
Morel I; Cillard J; Lescoat G; Sergent O; Pasdeloup N; Ocaktan AZ; Abdallah MA; Brissot P; Cillard P
Free Radic Biol Med; 1992 Nov; 13(5):499-508. PubMed ID: 1334028
[TBL] [Abstract][Full Text] [Related]
20. Relative oral efficacy and acute toxicity of hydroxypyridin-4-one iron chelators in mice.
Porter JB; Morgan J; Hoyes KP; Burke LC; Huehns ER; Hider RC
Blood; 1990 Dec; 76(11):2389-96. PubMed ID: 2257308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
